Resveratrol reduces radiation-induced chromosome aberration frequencies in mouse bone marrow cells

Radiation Research

Volumn 169, Issue 6, 2008, Pages 633-638

  Carsten, Ronald E ^a   Bachand, Annette M ^a   Baileya, Susan M ^a   Ullrich, Robert L ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESVERATROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CELL DAMAGE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DRUG MECHANISM; GAMMA RADIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION PROTECTION; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; CHROMOSOMES; GAMMA RAYS; MALE; MICE; MICE, INBRED CBA; MODELS, STATISTICAL; RADIATION-PROTECTIVE AGENTS; STILBENES; WHOLE-BODY IRRADIATION;

MUS;

EID: 44849128261     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1190.1     Document Type: Article

References (33)

1. M. Sowa, B. J. Arthurs, B. J. Estes and W. F. Morgan, Effects of ionizing radiation on cellular structures, induced instability and carcinogenesis. EXS 96, 293-301 (2006).
2. E. Elmore, X-Y. Lao, R. Kapadia and J. L. Redpath, The effect of dose rate on radiation-induced neoplastic transformation in vitro by low doses of low-LET radiation. Radiat. Res. 166, 832-838 (2006).
3. H. Suit, S. Goldberg, A. Niemierko, M. Ancukiewicz, E. Hall, M. Goitein, W. Wong and H. Paganetti, Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat. Res. 167, 12-42 (2007).
4. N. D. Turner, L. A. Braby, J. Ford and J. R. Lupton, Opportunities for nutritional amelioration of radiation-induced cellular damage. Nutrition 18, 904-912 (2002).
5. R. Arora, D. Gupta, R. Chawla, R. Sagar, A. Sharma, R. Kumar, J. Prasad, S. Singh, N. Samanta and R. K. Sharma, Radioprotection by plant products: Present status and future prospects. Phytother. Res. 19, 1-22 (2005).
6. A. M. Rimando, W. Kalt, J. B. Magee, J. Dewey and J. R. Ballington, Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. J. Agric. Food Chem. 52, 4713-4719 (2004).
7. J. Burns, T. Yokota, H. Ashihara, M. E. J. Lean and A. Crozier, Plant and herbal sources of resveratrol. J. Agric. Food Chem. 50, 3337-3340. (2002)
8. J. A. Baur and D. A. Sinclair, Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Disc. 5, 493-506 (2006).
9. Y. Li, Z. Cao and H. Zhu, Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol. Res. 53, 6-15 (2006).
10. G. A. Losa, Resveratrol modulates apoptosis and oxidation in human blood mononuclear cells. Eur. J. Clin. Invest. 33, 818-823 (2003).
11. M-V. Clement, J. L. Hirpara, S-H. Chawdhury and S. Pervaiz, Chemopreventive agent resveratrol, natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92, 996-1002 (1998).
12. C. Huang, W. Ma, A. Goranson and Z. Dong, Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20, 237-242 (1999).
13. Q-B. She, A. M. Bode, W-Y. Ma, N-Y. Chen and Z. Dong, Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular signal-regulated protein kinases and p38 kinase. Cancer Res. 61, 1604-1610 (2001).
14. Y-J. Surh, Y-J. Hurh, J-Y. Kang, E. Lee, G. Kong and S. J. Lee, Resveratrol, an antioxidant present in red wine, induces apoptosis in human promyelocytic leukemia (HL-60) cells. Cancer Lett. 140, 1-10 (1999).
15. L. Tessitore, A. Davit, I. Sarotto and G. Caderni, Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21 (CIP) expression. Carcinogenesis 21, 1619-1622 (2000).
16. D. Delmas, A. Lancon, D. Colin, B. Jannin and N. Latruffe, Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer. Curr. Drug Targets 7, 423-442 (2006).
17. J. K. Kundu and Y-J. Surh, Molecular basis of chemoprevention by resveratrol: NF-κB and AP-1 as potential targets. Mutat. Res. 555, 65-80 (2004).
18. E. Pozo-Guisado, A. Alvarez-Barrientos, S. Mulero-Navarro, B. Santiago-Josefat and P. M. Fernandez-Salguero, The antiproliferative activity of resveratrol results in apoptosis in MCF-7 but not MDA-MB-231 human breast cancer cells: cell-specific alteration of the cell cycle. Biochem. Pharmacol. 64, 1375-1386 (2002).
19. N. Kuwajerwala, E. Cifuentes, S. Gautam, M. Menon, E. R. Barrack and G. P. V. Reddy, Resveratrol induces prostate cancer cell entry into S phase and inhibits DNA synthesis. Cancer Res. 62, 2488-2492 (2002).
20. S. Baatout, H. Derradji, P. Jacquet, D. Ooms, A. Michaux and M. Mergeay, Enhanced radiation-induced apoptosis of cancer cell lines after treatment with resveratrol. Int. J. Mol. Med. 13, 895-902 (2004).
21. I. Zoberi, C. M. Bradbury, H. A. Curry, K. S. Bisht, P. C. Goswami, J. L. Roti Roti and D. Gius, Radiosensitizing and anti-proliferative effects of resveratrol in two human cervical tumor cell lines. Cancer Lett. 175, 165-173 (2002).
22. F. Scarlatti, G. Sala, C. Ricci, C. Maioli, F. Milani, M. Minella, M. Botturi and R. Ghidoni, Resveratrol sensitization of DU145 prostate cancer cells to ionizing radiation is associated with ceramide increase. Cancer Lett. 253, 124-130 (2007).
23. M. Fiore, F. Festa, T. Cornetta, R. Ricordy and R. Cozzi, Resveratrol affects X-ray induced apoptosis and cell cycle delay in human cells in-vitro. Int. J. Mol. Med. 15, 1005-1012 (2005).
24. J. Duraj, J. BoDo, M. Sulikova, P. Rauko and J. Sedlak, Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells. Neoplasma 53, 384-392 (2006).
25. H. Ferry-Dumazet, O. Garnier, M. Mamani-Matsuda, J. Vercauteren, F. Belloc, C. Billiard, M. Dupouy, D. Thiolat, J. P. Kolb and M. D. Mossalayi, Resveratrol inhibits the growth and induces apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23, 1327-1333 (2002).
26. 14C]- trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration. Life Sci. 72, 2219-2233 (2003).
27. + (p53 knockout) mice. Food Chem. Toxicol. 45, 55-63 (2007).
28. J. A. Crowell, P. J. Korytko, R. L. Morrissey, T. D. Booth and B. S. Levine, Resveratrol-associated renal toxicity. Toxicol. Sci. 82, 614-619 (2004).
29. M. E. Juan, M. P. Vinardell and J. M. Planas, The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J. Nutr. 132, 257-260 (2002).
30. J. M. Dai, D. C. Sun, R. X. Lin, J. Yang, S. Lou and S. Q. Wang, Microarray analysis of differentially expressed genes in mouse bone marrow tissues after ionizing radiation. Int. J. Radiat. Biol. 82, 511-521 (2006).
31. D. A. Gridley and M. J. Pecaut, Whole-body irradiation and long-term modification of bone marrow-derived cell populations by lowand high-LET radiation. In Vivo 20, 781-790 (2006).
32. J. S. Greenberger, M. W. Epperly, N. Jahroudi, K. L. Pogue-Geile, L. A. Berry, J. Bray and K. L. Goltry, Role of bone marrow stromal cells in irradiation leukomogenesis. Acta Haematol. 96, 1-15 (1996).
33. J. S. Greenberger, J. Anderson, L. A. Berry, M. Epperly, E. P. Cronkite and S. S. Boggs, Effects of irradiation of CBA/CA mice on hematopoietic stem cells and stromal cells in long-term bone marrow cultures. Leukemia 10, 514-527 (1996).